Cargando…

Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK

Anti-VEGF therapy has been proven to be effective in the treatment of pathological angiogenesis. However, therapy resistance often occurs, leading to development of alternative approaches. The present study examines if AMPK negatively regulates ALK1-mediated signaling events and associated angiogene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Ying, Ueta, Takashi, Jiang, Shanshan, Lin, Hui, Wang, Yuanyuan, Vavvas, Demetrios, Wen, Rong, Chen, Ye-Guang, Luo, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464828/ https://www.ncbi.nlm.nih.gov/pubmed/28427181 http://dx.doi.org/10.18632/oncotarget.15825

Ejemplares similares

Metformin attenuates trauma‐induced heterotopic ossification via inhibition of Bone Morphogenetic Protein signalling
por: Lin, Hui, et al.
Publicado: (2020)

Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation
por: Yang, Shumin, et al.
Publicado: (2013)

RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization
por: Ueta, Takashi, et al.
Publicado: (2019)

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
por: Yang, Fan, et al.
Publicado: (2019)

Activation of AMPK by simvastatin inhibited breast tumor angiogenesis via impeding HIF‐1α‐induced pro‐angiogenic factor
por: Wang, Ji‐Chang, et al.
Publicado: (2018)

Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK
por: Nassif, Rana M., et al.
Publicado: (2022)

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways
por: Zhu, Zhongling, et al.
Publicado: (2021)

Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion
por: Wang, Ji-Chang, et al.
Publicado: (2017)

AMPK inhibits Smad3‐mediated autoinduction of TGF‐β1 in gastric cancer cells
por: Zou, Junrong, et al.
Publicado: (2021)

Metformin: The next angiogenesis panacea?
por: Ren, Yu, et al.
Publicado: (2021)

Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation
por: Kim, Min Young, et al.
Publicado: (2019)

Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis
por: Theodoropoulou, Sofia, et al.
Publicado: (2013)

Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activation
por: Deng, Jun, et al.
Publicado: (2017)

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
por: Liu, Yuyang, et al.
Publicado: (2019)

Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway
por: Li, Sichen, et al.
Publicado: (2020)

Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021)

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
por: Cheng, Demin, et al.
Publicado: (2021)

Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition
por: Lai, Chien-Rui, et al.
Publicado: (2022)

Sirtuin 1–Mediated Cellular Metabolic Memory of High Glucose Via the LKB1/AMPK/ROS Pathway and Therapeutic Effects of Metformin
por: Zheng, Zhi, et al.
Publicado: (2012)

Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion
por: Chen, Yong, et al.
Publicado: (2020)

Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway
por: Cho, Kumsun, et al.
Publicado: (2015)

MLK3 Phophorylates AMPK Independently of LKB1
por: Luo, Lingyu, et al.
Publicado: (2015)

Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022)

Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
por: Shi, W-Y, et al.
Publicado: (2012)

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016)

Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway
por: Liu, Ke, et al.
Publicado: (2022)

Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts
por: Leclerc, Gilles M., et al.
Publicado: (2013)

AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages
por: Kumase, Fumiaki, et al.
Publicado: (2016)

Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis
por: Liu, Bingli, et al.
Publicado: (2023)

Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
por: Wu, Yanju, et al.
Publicado: (2019)

A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis
por: Kerr, Georgina, et al.
Publicado: (2015)

miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway
por: Li, Youkong, et al.
Publicado: (2020)

AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms
por: Dai, Yu-Lu, et al.
Publicado: (2015)

AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation
por: Kang, Lijing, et al.
Publicado: (2023)

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells
por: Mu, Qian, et al.
Publicado: (2018)

Metformin inhibits cholesterol-induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells
por: Liu, Qi, et al.
Publicado: (2021)

Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)

The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
por: Agius, Loranne, et al.
Publicado: (2020)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Corrigendum: Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway
por: Liu, Ke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8va2919llnedk31q6tv1bn766